DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES
Data sourced from IRS 990 public filings
DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES TO SUPPORT THE BUSINESS DEVELOPMENT OBJECTIVES OF ITS MEMBERS.
Annual Revenue
$5,945,287
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $5,945,287 | $4,743,473 | $9,760,385 |
| 2022 | $5,604,025 | $4,288,341 | $7,492,601 |
| 2021 | $4,118,876 | $3,649,686 | $6,347,497 |
| 2020 | $2,350,712 | $1,754,348 | $7,404,869 |
| 2019 | $2,085,976 | $2,257,469 | $6,336,316 |
| 2018 | $4,354,304 | $4,039,427 | $5,339,501 |
| 2017 | $4,530,305 | $4,093,859 | $4,491,270 |
| 2016 | $4,113,043 | $3,895,386 | $3,824,972 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2023 IRS 990 filing
Margaret Timony
Advisor to Executive Director
Melissa Schultea
Deputy Director
Patricia Van Arnum
Editorial Director
Lauryn Kuna
Director of Member Services
Miriam O'Donnell
Director of Technology
Carol Lee
Executive Director
CHARLES DAVIES
PRESIDENT
DONNA GRUOL
1ST V. PRESIDENT
Kelsey Achenbach
2nd V. President
Kenneth Seufert
3rd V. President
Showing 10 of 17 key personnel.
Frequently Asked Questions
Other Nonprofits in New Jersey
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.